These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6984402)

  • 1. [Hepatitis due to erythromycin ethylsuccinate].
    Funck-Brentano C; Danan G; Pessayre D; Benhamou JP
    Gastroenterol Clin Biol; 1982 Dec; 6(12):1044-5. PubMed ID: 6984402
    [No Abstract]   [Full Text] [Related]  

  • 2. [Acute hepatitis caused by erythromycin esters (propionate and ethylsuccinate)].
    Paliard P; Stremsdoerfer N; Moindrot H
    Gastroenterol Clin Biol; 1983 Jan; 7(1):100-1. PubMed ID: 6601598
    [No Abstract]   [Full Text] [Related]  

  • 3. Erythromycin ethylsuccinate hepatotoxicity.
    Sullivan D; Csuka ME; Blanchard B
    JAMA; 1980 Mar; 243(10):1074. PubMed ID: 6965509
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hepatitis caused by various derivatives of erythromycin].
    Funck-Brentano C; Pessayre D; Benhamou JP
    Gastroenterol Clin Biol; 1983 Apr; 7(4):362-9. PubMed ID: 6347792
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hepatotoxic syndrome caused by erythromycin ethyl succinate].
    Cocchi P; Silenzi M; Salvi G; Calabri G; Tamburini M; Alvisi P
    Minerva Pediatr; 1982 Jan; 34(1-2):68-9. PubMed ID: 6978458
    [No Abstract]   [Full Text] [Related]  

  • 6. Cholestatic hepatitis from erythromycin ethylsuccinate. Report of two cases.
    Diehl AM; Latham P; Boitnott JK; Mann J; Maddrey WC
    Am J Med; 1984 May; 76(5):931-4. PubMed ID: 6609640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged cholestasis and disappearance of interlobular bile ducts following chlorpropamide and erythromycin ethylsuccinate. Case of drug interaction?
    Geubel AP; Nakad A; Rahier J; Dive C
    Liver; 1988 Dec; 8(6):350-3. PubMed ID: 3265170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatotoxic reaction to erythromycin ethylsuccinate.
    Patel J; Schneider R
    South Med J; 1984 Oct; 77(10):1343-4. PubMed ID: 6333077
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatotoxicity to both erythromycin estolate and erythromycin ethylsuccinate.
    Keeffe EB; Reis TC; Berland JE
    Dig Dis Sci; 1982 Aug; 27(8):701-4. PubMed ID: 6980110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hepatotoxicity of erythromycin].
    García Buey L; García-Samaniego Rey J; González Estecha A; Pajares García JM
    Rev Clin Esp; 1989 Feb; 184(3):158. PubMed ID: 2785700
    [No Abstract]   [Full Text] [Related]  

  • 11. [Acute hepatitis caused by erythromycin propionate].
    Ponsot P; Théodore C; Larrey D; Breil P; Hugentobler JP; Paolaggi JA
    Gastroenterol Clin Biol; 1982; 6(6-7):594. PubMed ID: 7117770
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hepatotoxicity due to erythromycin ethylsuccinate].
    Caballeria Rovira E; Arago López JV; Masso Ubeda RM; Sanchis Closa A
    Rev Esp Enferm Dig; 1991 Nov; 80(5):356. PubMed ID: 1768482
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hepatotoxicity caused by erythromycin ethylsuccinate].
    Serrano Heranz R; Ziad F
    An Med Interna; 1990 Apr; 7(4):215. PubMed ID: 2103790
    [No Abstract]   [Full Text] [Related]  

  • 14. Selection of an oral erythromycin product.
    Fraser DG
    Am J Hosp Pharm; 1980 Sep; 37(9):1199-205. PubMed ID: 6998290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cholestatic hepatitis caused by erythromycin propionate].
    de Escalante B; Sampedro JA; Zabala S; Gracia P
    An Med Interna; 1990 Dec; 7(12):656. PubMed ID: 2135589
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cholestasis hepatitis caused by erythromycin propionate].
    Ortuño JA; Olaso V; Berenguer J
    Med Clin (Barc); 1984 May; 82(20):912. PubMed ID: 6748800
    [No Abstract]   [Full Text] [Related]  

  • 17. Erythromycin ethylsuccinate-induced cholestasis.
    Bachman BA; Boyd WP; Brady PG
    Am J Gastroenterol; 1982 Jun; 77(6):397-400. PubMed ID: 6979924
    [No Abstract]   [Full Text] [Related]  

  • 18. Modifications of the lymphocyte transformation test in a case of drug-induced cholestatic hepatitis.
    Victorino RM; Maria VA
    Diagn Immunol; 1985; 3(4):177-81. PubMed ID: 2935353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatotoxicity of erythromycin ethylsuccinate in a child.
    Phillips KG
    Can Med Assoc J; 1983 Sep; 129(5):411-2. PubMed ID: 6603894
    [No Abstract]   [Full Text] [Related]  

  • 20. Cholestasis and liver cell damage due to hypersensitivity to erythromycin stearate--recurrence following therapy with erythromycin succinate.
    Horn S; Aglas F; Horina JH
    Wien Klin Wochenschr; 1999 Jan; 111(2):76-7. PubMed ID: 10081126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.